$80.63
0.86[1.08%]
Last update: 1:03PM Get Real Time Here
Lantheus Holdings
(NASDAQ:LNTH)Latest News for Lantheus Holdings Stock (NASDAQ:LNTH)
Lantheus Holdings Stock (NASDAQ: LNTH)
Categories: All
Friday, May 03, 2024
- Evaluating Lantheus Holdings: Insights From 5 Financial AnalystsBenzinga Insights - May 3, 2024, 10:01AM
- Truist Securities Maintains Buy on Lantheus Holdings, Raises Price Target to $96Benzinga Newsdesk - May 3, 2024, 10:00AM
- Mizuho Maintains Buy on Lantheus Holdings, Raises Price Target to $100Benzinga Newsdesk - May 3, 2024, 8:10AM
Thursday, May 02, 2024
- C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - May 2, 2024, 10:28AM
- Lantheus shares are trading higher after the company reported better-than-expected Q1 results and raised its FY24 adjusted EPS outlook.Benzinga Newsdesk - May 2, 2024, 9:18AM
- Lantheus Sees Q2 Revenue Of $380m - $390M Vs. $356.1M Est; Adj EPS Of $1.81 - $1.86 Vs. $1.66 Est.Benzinga Newsdesk - May 2, 2024, 7:13AM
- Lantheus Raises FY24 Adj EPS Outlook From $6.50 - $6.70 To $7.00 - $7.20 Vs. $6.58 Est.Benzinga Newsdesk - May 2, 2024, 7:11AM
- Lantheus Holdings Q1 Adj $1.69 Beats $1.54 Estimate, Sales $370.00M Beat $348.45M EstimateBenzinga Newsdesk - May 2, 2024, 7:08AM
Thursday, April 18, 2024
Tuesday, March 19, 2024
Tuesday, March 05, 2024
Monday, March 04, 2024
Monday, February 26, 2024
Friday, February 23, 2024
Thursday, February 22, 2024
- Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Feb 22, 2024, 1:37PM
- NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Feb 22, 2024, 11:33AM
- Lantheus Holdings shares are trading higher after the company reported better-than-expected Q4 financial results. Also, the company issued Q1 revenue guidance above estimates and FY24 guidance above estimates.Benzinga Newsdesk - Feb 22, 2024, 11:14AM
- Lantheus Holdings Sees FY24 Revenues Of $1.41B-$1.445B Vs. $1.39B Estimate; Projects FY24 Adjusted EPS Of $6.50-$6.70 Vs. $6.25 EstimateBenzinga Newsdesk - Feb 22, 2024, 7:15AM
- Lantheus Holdings Expects Q1 Revenues Of $347M-$355M Vs. $336.41M Estimate, Projects Q1 Adjusted EPS Of $1.50-$1.54 Vs. $1.51 EstimateBenzinga Newsdesk - Feb 22, 2024, 7:13AM
- Lantheus Holdings Q4 Adj. EPS $1.75 Beats $1.45 Estimate, Sales $354.00M Beat $342.33M EstimateBenzinga Newsdesk - Feb 22, 2024, 7:04AM
- Earnings Scheduled For February 22, 2024Benzinga Insights - Feb 22, 2024, 5:27AM
Tuesday, February 13, 2024
Wednesday, January 10, 2024
Tuesday, January 09, 2024
- Lantheus To Purchase Equity Stake Of Up To 19.9% Of Perspective's Outstanding Shares For Up To ~$33MBenzinga Newsdesk - Jan 9, 2024, 8:06AM
- Perspective Therapeutics Enters Agreement With Lantheus Holdings; For Upfront Payment Of $28M In Cash, Lantheus Will Obtain Exclusive Option To Negotiate For Exclusive License To Perspective Therapeutics' Pb212-VMT-α-NETBenzinga Newsdesk - Jan 9, 2024, 8:05AM
- Lantheus Reports Preliminary FY23 Revenue Of $1.295B–$1.297B Versus Consensus Of $1.27B, Up 38%-39% Y/Y, Including A $15M Relistor Milestone AchievementBenzinga Newsdesk - Jan 9, 2024, 8:01AM
Tuesday, December 19, 2023
Monday, December 18, 2023
- Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Dec 18, 2023, 1:05PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Dec 18, 2023, 12:32PM
- Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today?Vandana Singh - Dec 18, 2023, 11:47AM
- Lantheus shares are trading lower after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.Benzinga Newsdesk - Dec 18, 2023, 9:09AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Dec 18, 2023, 8:08AM
- Lantheus and POINT Biopharma Announce Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate CancerBenzinga Newsdesk - Dec 18, 2023, 7:31AM
Monday, December 04, 2023
Thursday, November 30, 2023
Friday, November 03, 2023
Thursday, November 02, 2023
- 10 Health Care Stocks Whale Activity In Today's SessionBenzinga Insights - Nov 2, 2023, 1:35PM
- Lantheus Raises FY23 Adj EPS Guidance From $5.60 - $5.70 To $5.80 - $5.85 Vs. $5.68 Est.Benzinga Newsdesk - Nov 2, 2023, 7:13AM
- Lantheus Raises Lower End Of FY23 Revenue Guidance From $1.245B - $1.27B To $1.255B - $1.27B Vs. $1.26B Est.Benzinga Newsdesk - Nov 2, 2023, 7:12AM
- Lantheus Holdings Q3 Adj EPS $1.47 Beats $1.32 Estimate, Sales $319.90M Beat $314.28M EstimateBenzinga Newsdesk - Nov 2, 2023, 7:02AM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM